Our data unveil a new regulatory mechanism by which persistent extracellular ATP released by osteocyte Cx43 hemichannels, through its binding to purinergic receptor P2Y11R, down-regulates the CXCR4 receptor, a critical factor for breast cancer growth in the bone. Here, P2RX7 is linked to breast cancer.